Here is the truthful answer: VIP is not a typical-objective anti-inflammatory peptide it is possible to substitute into any protocol anticipating wide immune suppression. Its effects are receptor-particular, tissue-dependent, and timing-sensitive in ways that make protocol style and design noticeabl